| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021467 |
| Receipt No. | R000023157 |
| Official scientific title of the study | The effectiveness of prophylactic doses of intravenous nitroglycerin in preventing the incidence of myocardial ischemia under general anesthesia |
| Date of disclosure of the study information | 2016/03/14 |
| Last modified on | 2018/03/27 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | The effectiveness of prophylactic doses of intravenous nitroglycerin in preventing the incidence of myocardial ischemia under general anesthesia | |
| Title of the study (Brief title) | The effectiveness of prophylactic doses of intravenous nitroglycerin in preventing the incidence of myocardial ischemia under general anesthesia | |
| Region |
|
|
| Condition | ||
| Condition | myocardial ischemia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study was to evaluate whether prophylactic intravenous TNG can prevent the incidence of intraoperative myocardial ischemia for anesthesized patients. In addition, we also analyzed hemodynamic changes (heart rate [HR], mean blood pressure [MBP], and pulmonary capillary wedge pressure [PCWP]) from TNG in both pre and post anesthesia induction as an indicator of the decrease in preload. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | incidence of myocardial ischemia |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | This review included all randomized controlled trials investigating the incidence of MI associated with TNG compared with placebo in surgical patients. | |||
| Key exclusion criteria | We excluded observational studies and those published as an abstract. | |||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroshi Hoshijima |
| Organization | Saitama medical university hospital |
| Division name | Anesthesiology |
| Address | Saitama, Irumagunn, Moroyama, Morohongo38 |
| TEL | 049-276-1271 |
| hhoshi@saitama-med.ac.jp | |
| Public contact | |
| Name of contact person | Hiroshi Hoshijima |
| Organization | Saitama medical university hospital |
| Division name | Anesthesiology |
| Address | Saitama, Irumagunn, Moroyama, Morohongo38 |
| TEL | 049-276-1271 |
| Homepage URL | |
| hhoshi@saitama-med.ac.jp | |
| Sponsor | |
| Institute | Saitama medical university hospital, Anesthsiology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Saitama medical university hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | The purpose of this study was to evaluate whether prophylactic intravenous TNG can prevent the incidence of intraoperative myocardial ischemia for anesthesized patients. In addition, we also analyzed hemodynamic changes (heart rate [HR], mean blood pressure [MBP], and pulmonary capillary wedge pressure [PCWP]) from TNG in both pre and post anesthesia induction as an indicator of the decrease in preload. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023157 |